BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

962 related articles for article (PubMed ID: 19521263)

  • 1. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Petersson S; Shubbar E; Enerbäck L; Enerbäck C
    Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
    Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
    J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
    Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
    Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
    Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
    Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J; Cronin F; Duncan LM
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
    Bosserhoff AK; Moser M; Hein R; Landthaler M; Buettner R
    J Pathol; 1999 Mar; 187(4):446-54. PubMed ID: 10398105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signatures of microRNAs and selected microRNA target genes in human melanoma.
    Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
    Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma.
    Rust R; Visser L; van der Leij J; Harms G; Blokzijl T; Deloulme JC; van der Vlies P; Kamps W; Kok K; Lim M; Poppema S; van den Berg A
    Br J Haematol; 2005 Dec; 131(5):596-608. PubMed ID: 16351635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes.
    Curry JL; Richards HW; Huttenbach YT; Medrano EE; Reed JA
    J Cutan Pathol; 2009 Feb; 36(2):197-205. PubMed ID: 18647205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadherin expression in melanocytic naevi and malignant melanomas.
    Cowley GP; Smith ME
    J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of heat shock protein 105 in melanoma and melanocytic naevi.
    Muchemwa FC; Nakatsura T; Fukushima S; Nishimura Y; Kageshita T; Ihn H
    Melanoma Res; 2008 Jun; 18(3):166-71. PubMed ID: 18477890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development.
    Carlsson H; Petersson S; Enerbäck C
    Int J Oncol; 2005 Dec; 27(6):1473-81. PubMed ID: 16273201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin.
    Saitoh K; Takahashi H; Sawada N; Parsons PG
    J Pathol; 1994 Nov; 174(3):191-9. PubMed ID: 7823252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human melanoma cells express functional receptors for thyroid-stimulating hormone.
    Ellerhorst JA; Sendi-Naderi A; Johnson MK; Cooke CP; Dang SM; Diwan AH
    Endocr Relat Cancer; 2006 Dec; 13(4):1269-77. PubMed ID: 17158770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.
    Nambiar S; Mirmohammadsadegh A; Hassan M; Mota R; Marini A; Alaoui A; Tannapfel A; Hegemann JH; Hengge UR
    Carcinogenesis; 2007 Dec; 28(12):2501-10. PubMed ID: 17768177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reaction.
    Kan-Mitchell J; Liggett PE; Taylor CR; Rao N; Granada ES; Danenberg KD; White WL; Van Eldik LJ; Horikoshi T; Danenberg PV
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3366-75. PubMed ID: 8225871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple complementary transcripts of pCMa1, a novel gene located at chromosome 11p15.1-2, and melanocytic cell transformation.
    Meije CB; Das PK; Jans MM; Hau C; van der Wal AC; Alders M; Hakvoort TB; Weidle UH; Lamers WH; Swart GW
    J Pathol; 2002 Aug; 197(5):668-76. PubMed ID: 12210088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.